Question

What is the best country for stem cell therapy for Complex Regional Pain Syndrome?

There is no evidence-based best-country ranking for CRPS cell therapy. Prioritise a prospectively registered, regulator-authorised trial with a named sponsor, independent ethics review, defined manufacturing controls, CRPS and pain expertise, prespecified pain and functional endpoints and a public results plan. Destination marketing and clinic availability are not substitutes for evidence.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The cost picture for Complex Regional Pain Syndrome

Private investigational CRPS cell procedures can involve separate charges for assessment, repeat administration, monitoring, travel, accommodation and complication care. Prices do not indicate regulatory approval or expected pain relief. Patients should request an itemised written quote and verify sponsor, insurer and patient responsibilities. Evidence-based multidisciplinary CRPS care must not be delayed.

Am I a candidate? → · Complex Regional Pain Syndrome: full overview → · Complex Regional Pain Syndrome cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information